|Articles|March 9, 2016

WIRB-Copernicus Acquires Clintrax Global

Clintrax Global provides outsourced services for negotiating clinical trial-related contracts and budgets between biopharmaceutical, CROs and investigator sites.

WIRB-Copernicus Group® (WCG™) has acquired Clintrax Global, a services provider for negotiating clinical trial-related contracts and budgets between biopharmaceutical companies, CROs and investigator sites. Clintrax Global also manages, executes, and tracks payments between these global clinical trial participants. The acquisition allows WCG to offer clients a more comprehensive and integrated suite of study start-up solutions.

 

Read the full release.

 


Related to this article

© putilov_denis - © putilov_denis - stock.adobe.com
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.